bromocriptine

(redirected from Bromocriptine mesylate)
Also found in: Medical, Encyclopedia.
Related to Bromocriptine mesylate: hyperprolactinemia, Cabergoline

bro·mo·crip·tine

 (brō′mō-krĭp′tēn)
n.
An ergot alkaloid, C32H40BrN5O5, that is a dopamine antagonist and is used in its mesylate form to treat Parkinson's disease, acromegaly, and excessive prolactin secretion, and to reduce the size of certain pituitary tumors.

[bromo- + (ergo)cryptine, an ergot alkaloid (from German Ergokryptin : Ergo(t), ergot + Greek kruptos, hidden; see cryptic + -in, -in).]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

bromocriptine

(ˌbrəʊməʊˈkrɪptiːn)
n
a dopamine agonist drug which blocks the release of prolactin from the pituitary gland, used in the treatment of Parkinson's disease
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014
Translations

bromocriptine

n bromocriptina
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
Bromocriptine mesylate is different from conventional bromocriptine preparation used in the treatment of hyperprolactinaemia and Parkinson's disease.
Scranton, "Effect of bromocriptine-QR (a quick-release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjects," Journal of the American Heart Association, vol.
Octreotide Acetate Injection, a Somatostatin Analog, is indicated to reduce blood levels of growth hormone and IGF-I (somatomedin C) in acromegaly patients who have had inadequate response to or cannot be treated with surgical resection, pituitary irradiation, and bromocriptine mesylate at maximally tolerated doses, concluded the company.
The clinical management of this episode of NMS was similar to that used in the first episode--antipsychotic medication was stopped and she was given supportive and symptomatic treatment--but this time she was also treated with bromocriptine mesylate 10 mg/d.
Cycloset (quick-release bromocriptine mesylate), a novel centrally acting treatment for type 2 diabetes.
Bromocriptine mesylate salt and metoclopramide hydrochloride were purchased from Sigma (Milan, Italy).
Bromocriptine mesylate for prevention of postpartum lactation.
SHORTLY AFTER PUBLIC CITIZEN filed an August 1994 lawsuit against the Food and Drug Administration (FDA) to force the federal agency to ban Sandoz Pharmaceuticals Corporation's widely-used drug Parlodel (bromocriptine mesylate), the company advised the FDA that it was withdrawing the indication of the drug for post-partum lactation suppression from the U.S.
Bromocriptine mesylate is a quick release formulation of bromocriptine.
Cherrington, "Timed daily bromocriptine mesylate (BC) administration improves glucose disposal in a canine diet-induced model of impaired glucose tolerance," Diabetologia, vol.
15 November 2010 - US specialty biopharmaceutical company Santarus Inc (NASDAQ: SNTS) announced today the commercial launch of the Type 2 diabetes drug CYCLOSET (bromocriptine mesylate) tablets in the USA.
<p>Speciality biopharmaceutical company Santarus Inc (NASDAQ:SNTS) reported on Wednesday the execution of a distribution and licence agreement to acquire the exclusive rights to manufacture and commercialise CYCLOSET (bromocriptine mesylate) tablets in the US for type 2 diabetes.</p><p>This agreement was signed with S2 Therapeutics Inc and VeroScience LLC.</p><p>Pursuant to the agreement Santarus will pay an upfront fee of USD5m to S2 Therapeutics and VeroScience.